PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8055819-3 1993 The mean values of concentration decrement after the first, second and third week of treatment were 0.47, 0.37 and 0.26 mmol/l, respectively, (median values 0.56, 0.33 and 0.17 mmol/l) for fructosamine concentration, and 1.8, 2.9 and 1.0% (median 1.5, 2.3 and 0.8%) for HbA1. Fructosamine 189-201 hemoglobin subunit alpha 1 Homo sapiens 270-274 9547902-3 1998 HbA1c correlated better (r = 0.573) with mean blood glucose (MBG) concentration than did fructosamine Test Plus (r = 0.347), even after correction for total protein concentration (r = 0.463), while there was no significant correlation with the original fructosamine method (r = 0.201). Fructosamine 253-265 hemoglobin subunit alpha 1 Homo sapiens 0-4 9451409-5 1997 The relationship between the two measures was assessed by determining 95% prediction intervals for HbA1C from the regression equation relating mean HbA1C and fructosamine. Fructosamine 158-170 hemoglobin subunit alpha 1 Homo sapiens 99-103 8458194-4 1993 From Deming regression models, 95% prediction intervals for mean blood glucose for fructosamine and HbA1 values were calculated, showing that fructosamine predicted levels of mean blood glucose more precisely than HbA1. Fructosamine 142-154 hemoglobin subunit alpha 1 Homo sapiens 100-104 10615819-7 1999 In the diabetic group the significant positive correlation between EPO and maternal HbA1c and fructosamine levels was found as well as between EPO and fetal fructosamine levels. Fructosamine 94-106 hemoglobin subunit alpha 1 Homo sapiens 84-88 10615821-4 1999 That was found a significant positive correlation between Ic and maternal HbA1c and fructosamine levels as well as between Ic and neonatal birthweight in the diabetic group. Fructosamine 84-96 hemoglobin subunit alpha 1 Homo sapiens 74-78 3391095-4 1988 Fructosamine correlated moderately well with HbA1 (affinity; r = .8) and placed 71% of IDDM and 72% of NIDDM patients in the same clinical category of good, moderate, or poor control. Fructosamine 0-12 hemoglobin subunit alpha 1 Homo sapiens 45-49 1914798-8 1991 HbA1c correlated with fructosamine (r = 0.59) and Glyc PP-HPLC (r = 0.47) but correlated best with Glyc PP (r = 0.83). Fructosamine 22-34 hemoglobin subunit alpha 1 Homo sapiens 0-4 1942633-9 1991 In aged subjects with poor ADL, HbA1, HbA1c and plasma glucose should be determined with fructosamine. Fructosamine 89-101 hemoglobin subunit alpha 1 Homo sapiens 32-36 2692874-2 1989 Serum fructosamine correlated less closely with HbA1 (r = 0.44) than did HbA1 with glycated serum albumin (GSA) (r = 0.68). Fructosamine 6-18 hemoglobin subunit alpha 1 Homo sapiens 48-52 1934502-5 1991 Longitudinal analysis of individual patients" data over the 16-wk period showed a significant correlation between serum fructosamine and HbA1 (r = 0.55 to r = 0.94) which was present in 8 out of 14 patients. Fructosamine 120-132 hemoglobin subunit alpha 1 Homo sapiens 137-141 1934502-6 1991 The changes in fructosamine concentration preceded those observed in HbA1. Fructosamine 15-27 hemoglobin subunit alpha 1 Homo sapiens 69-73 1934502-7 1991 The ratio of fructosamine/HbA1 predicted the changes in HbA1 over the following month (r = 0.54, P less than 0.001). Fructosamine 13-25 hemoglobin subunit alpha 1 Homo sapiens 56-60 1934502-8 1991 Thus, we demonstrated that the parallel measurement of fructosamine and HbA1 provides information on future trends in HbA1 concentration in diabetic patients. Fructosamine 55-67 hemoglobin subunit alpha 1 Homo sapiens 118-122 2378195-3 1990 Fructosamine concentrations correlated significantly with fasting blood glucose and HbA1 in diabetics (r = 0.677, p less than 0.0005, and r = 0.598, p less than 0.0005, respectively). Fructosamine 0-12 hemoglobin subunit alpha 1 Homo sapiens 84-88 2378195-4 1990 The correlation between fructosamine and HbA1 was significant in the oral hypoglycemic-treated diabetics and poor in the insulin-treated diabetic group (r = 0.568, p less than 0.0005, and r = 0.526, p = 0.01). Fructosamine 24-36 hemoglobin subunit alpha 1 Homo sapiens 41-45 2351039-9 1990 Fructosamine correlated less well with both HbA1 (r = 0.55) and glucose (r = 0.51). Fructosamine 0-12 hemoglobin subunit alpha 1 Homo sapiens 44-48 2335179-6 1990 Serum fructosamine levels were closely correlated to the HbA1 levels. Fructosamine 6-18 hemoglobin subunit alpha 1 Homo sapiens 57-61 3254102-4 1988 Fructosamine correlated with HbA1 both in IDDM (n = 110, r = 0.701, P less than 0.001) and NIDDM (n = 71, r = 0.764, P less than 0.001). Fructosamine 0-12 hemoglobin subunit alpha 1 Homo sapiens 29-33 3254102-5 1988 Specificity and sensitivity of fructosamine for the prediction of degree of control assessed on the basis of HbA1 level (cut-off point for good vs. poor control, HbA1 = 10%) was determined. Fructosamine 31-43 hemoglobin subunit alpha 1 Homo sapiens 109-113 3254102-5 1988 Specificity and sensitivity of fructosamine for the prediction of degree of control assessed on the basis of HbA1 level (cut-off point for good vs. poor control, HbA1 = 10%) was determined. Fructosamine 31-43 hemoglobin subunit alpha 1 Homo sapiens 162-166 3365012-4 1988 There was a highly significant correlation between HbA1c and fructosamine in the diabetic children but this was lost when only concentrations within the established normal ranges were considered. Fructosamine 61-73 hemoglobin subunit alpha 1 Homo sapiens 51-55 3436113-2 1987 A significant correlation between fructosamine and HbA1 values (r = 0.70, p less than 0.001) was evidenced in Group A. Fructosamine 34-46 hemoglobin subunit alpha 1 Homo sapiens 51-55 26015742-3 2015 This study was done to measure the level of serum fructosamine and Glycated hemoglobin (HbA1c) in Gestational Diabetes mellitus (GDM) patients and to compare with pregnant women without diabetes and healthy non-pregnant adults, to determine the pattern of change in serum fructosamine, influence of serum fructosamine and HbA1c values and to evaluate the efficacy of patient"s treatment. Fructosamine 272-284 hemoglobin subunit alpha 1 Homo sapiens 88-92 3827184-3 1987 Glycated haemoglobin (HbA1) correlated with glycated albumin and fructosamine in the diabetic group. Fructosamine 65-77 hemoglobin subunit alpha 1 Homo sapiens 22-26 3954436-3 1986 Fructosamine correlated with HbA1 and with average glucose values measured over 30 days. Fructosamine 0-12 hemoglobin subunit alpha 1 Homo sapiens 29-33 3600671-6 1987 In the diabetic patients we found a significant correlation between serum fructosamine and HbA1 values (r = 0.87, p less than 0.001). Fructosamine 74-86 hemoglobin subunit alpha 1 Homo sapiens 91-95 29436378-7 2018 Equivalent concentrations of fructosamine and glycated albumin corresponding to an HbA1c of 6.5% (96.5 percentile) were 270.2 mumol/L and 15.6%, respectively. Fructosamine 29-41 hemoglobin subunit alpha 1 Homo sapiens 83-87 26015742-3 2015 This study was done to measure the level of serum fructosamine and Glycated hemoglobin (HbA1c) in Gestational Diabetes mellitus (GDM) patients and to compare with pregnant women without diabetes and healthy non-pregnant adults, to determine the pattern of change in serum fructosamine, influence of serum fructosamine and HbA1c values and to evaluate the efficacy of patient"s treatment. Fructosamine 272-284 hemoglobin subunit alpha 1 Homo sapiens 88-92 26015742-4 2015 In this study the level of fructosamine was positively correlated to HbA1c during 2(nd) trimesters of gestational period, implying that the level of fructosamine can be used to screen Gestational diabetes mellitus. Fructosamine 27-39 hemoglobin subunit alpha 1 Homo sapiens 69-73 26015742-4 2015 In this study the level of fructosamine was positively correlated to HbA1c during 2(nd) trimesters of gestational period, implying that the level of fructosamine can be used to screen Gestational diabetes mellitus. Fructosamine 149-161 hemoglobin subunit alpha 1 Homo sapiens 69-73 11762518-7 2001 This study indicates that the addition of weekly fructosamine values to daily blood glucose values provides both the patient and clinician valuable information to evaluate the impact of dietary, exercise, and medication therapy changes on glycemic control by bridging the existing gap between daily blood glucose values and quarterly HbA1c confirmation of intervention results. Fructosamine 49-61 hemoglobin subunit alpha 1 Homo sapiens 334-338